Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLITM (relacorilant)

Thursday, March 26, 2026 · onco360 oncology pharmacy

AI Briefing

Onco360 selected as national pharmacy partner for LIFYORLITM (relacorilant)
Corcept Therapeutics selects Onco360 for LIFYORLITM (relacorilant) treatment
Onco360 to provide LIFYORLITM (relacorilant) to patients with platinum-resistant ovarian cancer